Advancing the Science and Management of Renal Cell Carcinoma: Bridging the Divide between Academic and Community Practices

The treatment of metastatic renal cell carcinoma (mRCC) has rapidly evolved; however, the progress made in the field is heavily contingent upon timely and efficient accrual to clinical trials. While a substantial proportion of accrual occurs at tertiary care centers, community sites are playing an i...

Descripción completa

Detalles Bibliográficos
Autores principales: Salgia, Nicholas J., Philip, Errol J., Ziari, Mohammadbagher, Yap, Kelly, Pal, Sumanta Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290777/
https://www.ncbi.nlm.nih.gov/pubmed/32429554
http://dx.doi.org/10.3390/jcm9051508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290777/
https://www.ncbi.nlm.nih.gov/pubmed/32429554
http://dx.doi.org/10.3390/jcm9051508

Ejemplares similares